Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis.
Affiliation
Gynaecology Oncology Research Group, School of Cancer and Enabling Sciences, University of Manchester, Manchester, UK.Issue Date
2010-12
Metadata
Show full item recordAbstract
Body mass index (BMI) is a risk factor for endometrial cancer. We quantified the risk and investigated whether the association differed by use of hormone replacement therapy (HRT), menopausal status, and histologic type.Citation
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. 2010, 19 (12):3119-30 Cancer Epidemiol Biomarkers PrevJournal
Cancer Epidemiology, Biomarkers & PreventionDOI
10.1158/1055-9965.EPI-10-0832PubMed ID
21030602Type
ArticleLanguage
enISSN
1538-7755ae974a485f413a2113503eed53cd6c53
10.1158/1055-9965.EPI-10-0832